Sensate raised more than $1 million in funding for its stress management device in an investment round.
The company's device uses infrasonic therapy to soothe the body's nervous system, according to a Sept. 7 news release from Sensate.
"We're raising from retail investors this time around because we also want our users, supporters, and everyone in between to have access to our upside alongside our institutional investors," Anna Gudmundson, CEO of Sensate, said in the release.